Biogen (NASDAQ:BIIB) Stock Price Down 6.8% Following Analyst Downgrade
Biogen Inc. (NASDAQ:BIIB – Get Free Report) traded down 6.8% during trading on Wednesday after Bank Of America (Bofa) lowered their price target on the stock from $178.00 to $163.00. Bank Of America (Bofa) currently has a neutral rating on the stock. Biogen traded as low as $128.51 and last traded at $129.86. 973,287 shares […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) traded down 6.8% during trading on Wednesday after Bank Of America (Bofa) lowered their price target on the stock from $178.00 to $163.00. Bank Of America (Bofa) currently has a neutral rating on the stock. Biogen traded as low as $128.51 and last traded at $129.86. 973,287 shares […]
